Home » Vivus Receives $140 Million Milestone Payment From KV Pharma
Vivus Receives $140 Million Milestone Payment From KV Pharma
Vivus, Inc. has received a $140 million milestone payment from KV Pharmaceutical (KV) pursuant to the previously announced transfer of exclusive rights and assets related to Evamist.
Pharmabiz
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May